Advertisement
CHICAGO, Dec. 1, 2015 /PRNewswire/ -- At this year's Radiological Society of North America (RSNA), November 29-December 4 in Chicago, Imalogix introduces its new Premium Edition™, a cloud-based solution designed to remove and solve the complexity of recently adopted Joint Commission Dose standards. A first of its kind, Imalogix Premium Edition™ is a single source offering that partners with a centralized team of world renowned physicists with a cloud-based imaging and dose performance solution. This unique solution provides healthcare organizations a partner beyond dose tracking software.
With Imalogix Premium Edition™ a hospital's local team has remote access to physicists with vast experience to consult on the Joint Commission Process for dose compliance to help set up to document and track dose, manage protocols, set reference levels, identify outliers and benchmark performance. Organizations will obtain guidance on how to set up a Clinical Dose Optimization Committee with ongoing participation from a physicist, receive counsel to establish expected dose ranges and recommended alert levels, consultation in optimization of imaging protocols and monitoring by a physicist of dose tracking and support for alerts. Site data is benchmarked against national standards. Customers also will have access to best practices from over 100 participating hospitals.
"Imalogix Premium Edition™ offers healthcare organizations one stop shopping to navigate and meet dose regulations. With access to experienced top-notch physicists combined with our cloud-based imaging and dose performance solution, this will help organizations save time and money to meet regulations. This is a game changer for the industry. We are offering the first out of the box solution that addresses the complexity beyond dose tracking and reporting to help solve the complex issues surrounding the process to meet dose regulations," says John Heil CEO of Imalogix.
Further information is available at booth #1904 at RSNA, or visit www.imalogix.com.
About medInt Holdings, LLC d.b.a. Imalogix
Headquartered in King of Prussia, Pa., medInt Holdings, LLC is a Healthcare IT company that integrates with the diagnostic and therapeutic disciplines, turning data into usable knowledge to improve patient safety, increase quality and save lives. Its flagship product, Imalogix™, helps you manage your risk by providing the industry's only enterprise platform to protect your imaging business, your patients, your providers and your margins. For more information, please visit www.imalogix.com.
Advertisement
With Imalogix Premium Edition™ a hospital's local team has remote access to physicists with vast experience to consult on the Joint Commission Process for dose compliance to help set up to document and track dose, manage protocols, set reference levels, identify outliers and benchmark performance. Organizations will obtain guidance on how to set up a Clinical Dose Optimization Committee with ongoing participation from a physicist, receive counsel to establish expected dose ranges and recommended alert levels, consultation in optimization of imaging protocols and monitoring by a physicist of dose tracking and support for alerts. Site data is benchmarked against national standards. Customers also will have access to best practices from over 100 participating hospitals.
"Imalogix Premium Edition™ offers healthcare organizations one stop shopping to navigate and meet dose regulations. With access to experienced top-notch physicists combined with our cloud-based imaging and dose performance solution, this will help organizations save time and money to meet regulations. This is a game changer for the industry. We are offering the first out of the box solution that addresses the complexity beyond dose tracking and reporting to help solve the complex issues surrounding the process to meet dose regulations," says John Heil CEO of Imalogix.
Further information is available at booth #1904 at RSNA, or visit www.imalogix.com.
About medInt Holdings, LLC d.b.a. Imalogix
Headquartered in King of Prussia, Pa., medInt Holdings, LLC is a Healthcare IT company that integrates with the diagnostic and therapeutic disciplines, turning data into usable knowledge to improve patient safety, increase quality and save lives. Its flagship product, Imalogix™, helps you manage your risk by providing the industry's only enterprise platform to protect your imaging business, your patients, your providers and your margins. For more information, please visit www.imalogix.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-imalogix-premium-edition-offers-industry-first-single-source-software-solution-with-world-renowned-physicists-to-meet-dose-regulations-300186338.html
SOURCE Imalogix
